Thomas Malley, Director at Kura Oncology, Inc. (KURA), bought 50,000 shares at $8.00 ($400K) on 2015-11-10, disclosed to the SEC on 2015-12-17.
Open-market purchase of $400k KURA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |
| OVAS | BUY | 2015-01-15 | $1.8M | — | Filing → |